SenesTech (NASDAQ:SNES) is set to post its quarterly earnings results after the market closes on Wednesday, May 15th.
SenesTech (NASDAQ:SNES) last announced its quarterly earnings data on Thursday, March 28th. The company reported ($0.10) earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of ($0.10). SenesTech had a negative net margin of 4,009.43% and a negative return on equity of 182.12%. The company had revenue of $0.14 million during the quarter, compared to analysts’ expectations of $0.58 million.
Shares of SenesTech stock opened at $1.69 on Tuesday. SenesTech has a 52-week low of $0.30 and a 52-week high of $2.37. The firm has a market capitalization of $39.56 million, a PE ratio of -2.68 and a beta of 1.67. The company has a debt-to-equity ratio of 0.04, a current ratio of 5.74 and a quick ratio of 4.65.
ILLEGAL ACTIVITY WARNING: “SenesTech (SNES) Scheduled to Post Quarterly Earnings on Wednesday” was originally reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this piece on another site, it was copied illegally and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://www.baseballdailydigest.com/news/2019/05/14/senestech-snes-scheduled-to-post-quarterly-earnings-on-wednesday.html.
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment.
Further Reading: Are all No-Load Funds Equal?
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.